The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Background: The emergence of the coronavirus disease 2019 (COVID-19) has brought large challenges to dementia patients. We reviewed the existing literature on COVID-19 to assess the incidence and mortality of dementia comorbidities in COVID-19 patients. Objective: To investigate the impact of pre-existing dementia comorbidities on COVID-19. Methods: We searched the PubMed, Embase, and Web of Science databases for patients with preexisting dementia who were diagnosed with COVID-19. The statistical data on the prevalence and mortality of dementia comorbidities were examined. A fixed-or random-effect model was used to calculate the overall pooled risk estimates. Forest plots were generated to show the summarized results. Results: A total of 265 articles were retrieved from the three databases. After removing duplicates and performing two screenings, 10 articles were selected for meta-analysis, including 119,218 participants. Overall, the meta-analysis of the 10 studies showed that the incidence of dementia in COVID-19 patients was (R: 9%, [95% CI: 6% to 13%]). Moreover, the meta-analysis of 9 studies showed that the mortality rate of individuals with dementia after being infected with COVID-19 was higher than that of individuals with no dementia (OR: 5.17 [95% CI: 2.31 to 11.59]). Substantial heterogeneity was observed in this meta-analysis. Significant publication bias was also found. Conclusion: Emerging literature shows that dementia comorbidities are a high risk factor for the prevalence and mortality of COVID-19. Our results should have an impact on preventive interventions and encourage more targeted approaches to prioritize older people with specific risk factors, such as dementia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“People with dementia had around five times the mortality from COVID-19 (meta-analysis of 10 studies OR 5.17, 2.31- 11.59; n=119,218) compared to those without dementia (554)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [554]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“I2 ≤ 50% was considered to have little heterogeneity; I2 > 50% was considered to have substantial heterogeneity [18].”
BackgroundClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationZhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · cited 1×
“Since the first case was detected in Wuhan, China in December 2019, a novel type of coronavirus named coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus2 (SARS-CoV-2) has become a global pandemic threat [1].”
BackgroundSelf-citationStang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396 · cited 1×
“The Newcastle-Ottawa Scale (NOS) recommended by the Cochrane Collaboration was used to assess the methodological quality of the included studies [17].”
Method2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
Nikolich-Zugich, J., Knox, K. S., Rios, C. T., Natt, B., Bhattacharya, D., & Fain, M. J. (2020) · GeroScience · doi:10.1007/s11357-020-00186-0 · Cited by 577 · cited 1×
“ties of vascular diseases [7], people with dementia”
BackgroundPreexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort
Atkins, J. L., Masoli, J. A. H., Delgado, J., Pilling, L. C., Kuo, C.-L., Kuchel, G. A., & Melzer, D. (2020) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glaa183 · Cited by 498 · cited 3×
“Two were conducted in the United States [19, 22], 6 were conducted in Europe [13, 14, 20, 21, 24, 25], and 2 were conducted in Asia [15, 23].”
BackgroundBrown, E. E., Kumar, S., Rajji, T. K., Pollock, B. G., & Mulsant, B. H. (2020) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.04.010 · Cited by 483 · cited 4×
“Our study found that 9% of patients infected with COVID19 have dementia comorbidities.”
BackgroundInfluentialClinical presentation of COVID19 in dementia patients
Bianchetti, A., Rozzini, R., Guerini, F., Boffelli, S., Ranieri, P., Minelli, G., Bianchetti, L., & Trabucchi, M. (2020) · The Journal of nutrition, health and aging · doi:10.1007/s12603-020-1389-1 · Cited by 305 · cited 3×
“Two were conducted in the United States [19, 22], 6 were conducted in Europe [13, 14, 20, 21, 24, 25], and 2 were conducted in Asia [15, 23].”
Background
Cited by
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
Palaniappan, L. P., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Currie, M. E., Earlie, R. S., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001412 · Cited by 242
Bennett, T. D., Moffitt, R. A., Hajagos, J. G., Amor, B., Anand, A., Bissell, M. M., Bradwell, K. R., Bremer, C., Byrd, J. B., Denham, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.16901 · Cited by 231
“7) (n = 3106) Hospital LOS, median (IQR), d NR NR 4 (2-8) (n = 25 906) 23 (12-37) (n = 2790) 9 (4-18) (n = 3775)”
Fond, G., Nemani, K., Etchecopar-Etchart, D., Loundou, A., Goff, D. C., Lee, S. W., Lancon, C., Auquier, P., Baumstarck, K., Llorca, P.-M., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.2274 · Cited by 224
Treskova-Schwarzbach, M., Haas, L., Reda, S., Pilic, A., Borodova, A., Karimi, K., Koch, J., Nygren, T., Scholz, S., Schönfeld, V., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02058-6 · Cited by 218
“Circulatory diseases Venous thromboembolism Hospital mortality; hospitalisation; intubation 9 [29, 39, 54, 70, 78, 97, 114, 120, 133] 4 3 [233, 235, 272] UK; USA 238– 3703 low moderate”
BackgroundInfluentialRisk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Zsichla, L., & Müller, V. (2023) · Viruses · doi:10.3390/v15010175 · Cited by 138
Bamford, C., Wheatley, A., Brunskill, G., Booi, L., Allan, L. M., Banerjee, S., Dening, K. H., Manthorpe, J., Robinson, L. A., & on behalf of the PriDem study team (2021) · PLoS ONE · doi:10.1371/journal.pone.0260506 · Cited by 99
Dementia wellbeing and COVID-19: review and expert consensus on current research and knowledge gaps
Liu, K. Y., Howard, R., Banerjee, S., Comas‐Herrera, A., Goddard, J., Knapp, M., Livingston, G., Manthorpe, J., O'Brien, J. T., Paterson, R. W., et al. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5567 · Cited by 87
Effects of COVID-19 on cognition and brain health
Zhao, S., Toniolo, S., Hampshire, A., & Husain, M. (2023) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2023.08.008 · Cited by 100
“higher mortality rate [142] compared to patients without dementia.”
BackgroundState of the science on brain insulin resistance and cognitive decline due to Alzheimer's disease
Rhea, E. M., Leclerc, M., Yassine, H. N., Capuano, A. W., Tong, H., Petyuk, V. A., Macauley, S. L., Fioramonti, X., Carmichael, O., Calon, F., et al. (2023) · Aging and disease · doi:10.14336/ad.2023.0814 · Cited by 70
“On the one hand, both T2DM and dementia due to AD increase the risk of SARS-CoV-2 infection and the severity of COVID-19 [24, 25].”
BackgroundMukamel, D. B., Saliba, D., Ladd, H., & Konetzka, R. T. (2023) · Health Affairs · doi:10.1377/hlthaff.2022.01263 · Cited by 59
Prommas, P., Lwin, K. S., Chen, Y. C., Hyakutake, M., Ghaznavi, C., Sakamoto, H., Miyata, H., & Nomura, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101839 · Cited by 67
The National COVID Cohort Collaborative: Clinical Characterization and Early Severity PredictionPreprint
Bennett, T. D., Moffitt, R. A., Hajagos, J., Amor, B., Anand, A., Bissell, M. M., Bradwell, K. R., Bremer, C., Byrd, J. B., Denham, A., et al. (2021) · medRxiv · doi:10.1101/2021.01.12.21249511 · Cited by 57
Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?
Rudnicka-Drożak, E., Drożak, P., Mizerski, G., Zaborowski, T., Ślusarska, B. J., Nowicki, G., & Drożak, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20032146 · Cited by 61
Saragih, I. D., Saragih, I. S., Batubara, S. O., & Lin, C. (2021) · Geriatric Nursing · doi:10.1016/j.gerinurse.2021.03.007 · Cited by 57
Huang, P., Zhang, L., Tan, Y., & Chen, S. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00337-1 · Cited by 63
Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again?
Xiong, N., Schiller, M. R., Li, J., Chen, X., & Lin, Z. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00858-9 · Cited by 45
“Background In the midst of the COVID-19 pandemic, patients with Alzheimer’s disease (AD), once infected by the underlying coronavirus SARS-CoV-2, are 5 times likely to die of this infectious disease [1].”
BackgroundKuper, H., & Smythe, T. (2023) · Public Health · doi:10.1016/j.puhe.2023.06.032 · Cited by 44
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t
Lingor, P., Demleitner, A. F., Wolff, A. W., & Feneberg, E. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02500-w · Cited by 39
Ahmed, R., Fahad, N., Miah, M. S. U., Hossen, M. J., Morol, M. K., Mahmud, M., & Rahman, M. (2024) · Healthcare Analytics · doi:10.1016/j.health.2024.100362 · Cited by 41
Lozano-Montoya, I., Quezada-Feijoó, M., Jaramillo-Hidalgo, J., Garmendia-Prieto, B., García, P. C., & Gómez‐Pavón, J. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00541-0 · Cited by 35
“The ApoE4 genotype has also been associated with a probable increase in the development of the cytokine storm whose effects can be more deleterious in patients with dementia who already have a higher baseline inflammatory state [23].”
BackgroundDementia Clinical Care in Relation to COVID-19
Bianchetti, A., Rozzini, R., Bianchetti, L., Coccia, F., Guerini, F., & Trabucchi, M. (2022) · Current Treatment Options in Neurology · doi:10.1007/s11940-022-00706-7 · Cited by 31
Vrillon, A., Mhanna, E., Aveneau, C., Bozec, M. L., Grosset, L., Nankam, D., Albuquerque, F., Feroldi, R. R., Maakaroun, B., Pissareva, I., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00820-9 · Cited by 37
Li, W., Sun, L., Yue, L., & Xiao, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1120495 · Cited by 34
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study
Pisaturo, M., Calò, F., Russo, A., Camaioni, C., Giaccone, A., Pinchera, B., Gentile, I., Simeone, F., Iodice, A., Maggi, P., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.698184 · Cited by 28
Neurological complications of COVID-19
Dai, X., Cao, X., Jiang, Q., Wu, B., Lou, T., Shao, Y., Hu, Y., & Lan, Q. (2022) · QJM · doi:10.1093/qjmed/hcac272 · Cited by 27
Wang, Y., Li, M., Kazis, L. E., & Xia, W. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12665 · Cited by 23
Carmona‐Pírez, J., Miguel, A. G., Bliek-Bueno, K., Poblador‐Plou, B., Díez‐Manglano, J., Ioakeim‐Skoufa, I., González‐Rubio, F., Poncel-Falcó, A., Prados‐Torres, A., Gimeno-Feliú, L. A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-06838-9 · Cited by 28
Markiewicz-Gospodarek, A., Górska, A., Markiewicz, R., Chilimoniuk, Z., Czeczelewski, M., Baj, J., Maciejewski, R., & Masiak, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19159573 · Cited by 25
Molecular cross-talk between long COVID-19 and Alzheimer’s disease
Pszczołowska, M., Walczak, K., Miśków, W., Antosz, K., Batko, J., Karska, J., & Leszek, J. (2024) · GeroScience · doi:10.1007/s11357-024-01096-1 · Cited by 26
Hicks, B., Read, S., Hu, B., Wittenberg, R., Grahamslaw, A., Karim, A., Martin, E., Nuzum, E., Reichental, J., Russell, A., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12236 · Cited by 21
SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants
Khamees, A., Bani-Issa, J., Zoubi, M. S. A., Qasem, T., Alarjah, M. I. A., Alawadin, S. A., Al‐Shami, K., Hussein, F. H., Hussein, E. I., Bashayreh, I. H., et al. (2022) · Pathogens · doi:10.3390/pathogens11020275 · Cited by 20
“SARSCoV-2 belongs to the Coronaviridae family, a group of associated viruses with a singlestranded RNA that may cause respiratory infection with mild to lethal symptoms [1,2].”
BackgroundResultPomilio, A. B., Vitale, A. A., & Lazarowski, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666221003101548 · Cited by 20
Smadi, M., Kaburis, M., Schnapper, Y., Reina, G., Molero, P., & Molendijk, M. L. (2023) · The British Journal of Psychiatry · doi:10.1192/bjp.2023.43 · Cited by 20
Cascini, S., Agabiti, N., Marino, C., Acampora, A., Balducci, M. T., Calandrini, E., Davoli, M., & Bargagli, A. M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220369 · Cited by 19
Shrestha, A., Chen, R., Kunasekaran, M. P., Honeyman, D., Notaras, A., Sutton, B. P., Quigley, A. L., & MacIntyre, C. R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102448 · Cited by 20
Long-term outcomes of patients with a pre-existing neurological condition after SARS-CoV-2 infection
Hadidchi, R., Al‐Ani, Y., Choi, S., Renteria, S., Duong, K. S., Henry, S. S., Wang, S. H., & Duong, T. Q. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123477 · Cited by 17
“…were all-cause mortality, major adverse cardiovascular events (MACE), and secondary outcomes were the development of altered mental status, fatigue, sleep disturbances, dyspnea, headache, depression, and anxiety, which are among the most common post-COVID-19 symptoms and disorders 14, 15, 22 .”
Visos‐Varela, I., Zapata‐Cachafeiro, M., Piñeiro‐Lamas, M., Carracedo‐Martínez, E., Sáez, M., Herdeiro, M. T., Figueiras, A., & Salgado‐Barreira, Á. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.03.011 · Cited by 16
Predictors of COVID‑19‑associated mortality among hospitalized elderly patients with dementia
Georgakopoulou, V., Gkoufa, A., Tsakanikas, A., Makrodimitri, S., Karamanakos, G., Basoulis, D., Voutsinas, P., Eliadi, I., Bougea, A. M., Spandidos, D. A., et al. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12094 · Cited by 16
“Dementia is a well‐established predictor of a higher mortality rate globally (2), and individuals with dementia may be a particularly high‐risk subgroup for both infection (2,3) and negative consequences due to COVID‐19 infection (4,5).”
Clinical management of COVID-19: living guideline, June 2025
World Health Organization (2025) · World Health Organization eBooks · doi:10.2471/b09467 · Cited by 62
Dementia and COVID-19: A Case Report and Literature Review on Pain Management
Scuteri, D., Contrada, M., Tonin, P., Corasaniti, M. T., Nicotera, P., & Bagetta, G. (2022) · Pharmaceuticals · doi:10.3390/ph15020199 · Cited by 15
“Patients affected by Alzheimer’s disease (AD) have contracted the infection more frequently and present increased risk of death [2,3].”
BackgroundPark, J. M., Woo, W., Lee, S. C., Park, S., Yon, D. K., Lee, S. W., Smith, L., Koyanagi, A., Shin, J. I., & Kim, Y. W. (2023) · Neuroepidemiology · doi:10.1159/000530536 · Cited by 16
Wong, R., & Lovier, M. A. (2022) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5735 · Cited by 14
Aguilar‐Palacio, I., Maldonado, L., Marcos-Campos, I., Castel-Feced, S., Malo, S., Remón, C. A., & Rabanaque, M. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.928174 · Cited by 15
Bicalho, M. A. C., Aliberti, M. J. R., Delfino-Pereira, P., Chagas, V. S., Rosa, P. M. D. S., Pires, M. C., Ramos, L. E. F., Bezerra, A. F. B., Feres, A. B. D. C., Gomes, A. G. D. R., et al. (2024) · BMC Geriatrics · doi:10.1186/s12877-023-04494-w · Cited by 15
“On the contrary, two systematic reviews and meta-analyses showed that individuals with dementia presented a higher risk of death than those without dementia [5, 26].”
Addressing Suicide Risk in Patients Living With Dementia During the COVID-19 Pandemic and Beyond
Portacolone, E., Byers, A. L., Halpern, J., & Barnes, D. E. (2022) · The Gerontologist · doi:10.1093/geront/gnac042 · Cited by 12
Kostev, K., Geßler, N., Wohlmuth, P., Arnold, D., Bein, B., Bohlken, J., Herrlinger, K. R., Jacob, L., Koyanagi, A., Nowak, L., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220918 · Cited by 10
“A meta-analysis of 9 studies published in 2020 showed that the mortality rate of individuals with COVID-19 and dementia was 5.1 times higher than that of individuals with COVID-19 and no dementia [16].”
InfluentialSečník, J., Eriksdotter, M., Xu, H., Annetorp, M., on behalf of the SweGeroCOVID Project, Rytarowski, A., Johnell, K., Hägg, S., & Religa, D. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01154-w · Cited by 11
“First, patients with dementia are more prone to being infected and hospitalized with COVID-19 [7, 8, 15, 31, 32] and suffer more frequently from severe outcomes of COVID-19 [7, 9, 10].”
BackgroundFreudenberg‐Hua, Y., Makhnevich, A., Li, W., Liu, Y., Qiu, M., Marziliano, A. M., Carney, M. T., GREENWALD, B. S., Kane, J. M., Diefenbach, M. A., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.841326 · Cited by 9
Wang, X., Jiang, D., Li, T., Zhang, X. L., Wang, R., Gao, S., Yang, F., Wang, Y., Tian, Q., Xie, C., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.991085 · Cited by 7
Self-citationYang, J., Song, H., & Hao, X. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28177 · Cited by 7
Relevance of comorbidities for main outcomes during different periods of the COVID‐19 pandemic
Quintana, J. M., Rodriguez-Idiazabal, L., Portuondo, J., García, J., Legarreta, M. J., Gascón, M., Larrea, N., & Barrio, I. (2024) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13240 · Cited by 11
“In the first period, dementia and liver disease were relevant instead of cancer and cerebrovascular disease.”
Jo, S., Nam, H.-K., Kang, H., & Cho, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273654 · Cited by 7
“This is consistent with reports that hypertension, diabetes, heart disease [32–34], chronic kidney disease [35], malignancy [36,37], and dementia [38] are the most common comorbidities of COVID-19 and are associated with a higher risk for mortality.”
ResultRadomyslsky, Z., Kivity, S., Lidar, S., Bentur, N., Korn, L., Gannot, R. N., Sternberg, S. A., Hochwald, I. H., Reges, O., Alon, Y., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1281266 · Cited by 9
Supporting and Protecting People with Dementia in the COVID-19 Pandemic
Remoli, G., Canevelli, M., Robertazzo, U. M., Nuti, F., Bacigalupo, I., Salvi, E., Valletta, M., Blasi, M. T., Cesari, M., Vanacore, N., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210264 · Cited by 6
“People with dementia have been disproportionately affected by the COVID-19 pandemic, from multiple perspectives [1].”
BackgroundSavla, J. T., Roberto, K. A., McCann, B. R., & Blieszner, R. (2022) · Journal of Applied Gerontology · doi:10.1177/07334648221147916 · Cited by 6
“…virus that emerged in December 2019, exacerbated the vulnerability of PLwD due to the morbidity and mortality associated with this respiratory illness as well as the indirect consequences of the COVID-19 pandemic on the social support and healthcare system on which they rely (Liu et al., 2020).”
BackgroundThunell, J. A., Ferido, P., & Zissimopoulos, J. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18230 · Cited by 6
“Although recent meta-analyses synthesizing these results point to higher risk of infection, severity, and death among PLWD, there was considerable variability in estimated effect size, including no effect.(11,14) Studies in the older population demonstrated racial/ethnic disparities in COVID-19 risk and outcomes: non-…”
ResultSchöning, V., Liakoni, E., Drewe, J., & Hammann, F. (2021) · medRxiv · doi:10.1101/2021.03.25.21254314 · Cited by 8
Choroid plexus alterations in long COVID and their associations with Alzheimer's disease risks
Pang, H., Frontera, J., Jiang, L., Li, C., Boutajangout, A., Sun, Z., Debure, L., Ghuman, M., Vedvyas, A., Masurkar, A. V., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71020 · Cited by 6
“5 Besides, individuals with AD exhibit increased mortality after COVID-19 infection, 6 suggesting potential overlaps in the pathogenic mechanisms of COVID-19 and AD.”
Peláez, A., del Árbol, N. R., Sellán, A. V., Castellano, J. M., Soriano, J. B., Ancochea, J., & Peñalvo, J. L. (2024) · Medicina Clínica · doi:10.1016/j.medcli.2023.12.030 · Cited by 8
Kazawa, K., Akishita, M., Ikeda, M., Iwatsubo, T., & Ishii, S. (2021) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14307 · Cited by 4
Priori, A., Bai, F., Rovito, R., Marchetti, G. C., Monforte, A. D., Papa, G. F. S., Pellegrino, G. M., Centanni, S., Chiumello, D., Bonifazi, M., et al. (2021) · doi:10.54103/milanoup.57 · Cited by 5
Mayer, C., Woo, M. S., Brehm, T. T., Heyer, A., Fischer, M., Fischbach, F., Bal, L. C., Addo, M. M., Kluge, S., Thomalla, G., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.15843 · Cited by 5
“These results differ from earlier reports that described increased mortality and risk for ICU admission for patients with pre- existing dementia [16, 17].”
ResultKwon, H. S., Sung, W., Park, K., Kim, S. H., Koh, S., Lim, J., & Choi, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-58316-z · Cited by 4
“However, it was unexpected that there were no significant differences in mortality rates before and after February 2020, considering that individuals with dementia are known to have a higher risk for the acquisition and mortality from COVID-19 infection 12 .”
BackgroundJohnson, A. L., Chin, N. A., Piasecki, T. M., Conner, K. L., Baker, T. B., Fiore, M. C., & Slutske, W. S. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14136 · Cited by 6
“7,8 However, the increased risk of mortality associated with all-cause dementia is much lower than reportedinpreviousstudies.”
Valletta, M., Canevelli, M., D’Antonio, F., Trebbastoni, A., Talarico, G., Campanelli, A., Monti, M. S., Vita, A. D., Salati, E., Imbriano, L., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220077 · Cited by 5
“been observed in cognitively impaired people, and several studies reported dementia among the main risk factors for severe COVID-19 [1, 2].”
BackgroundNawaz, A. D., Haider, M. Z., & Akhtar, S. (2024) · Biomolecules and Biomedicine · doi:10.17305/bb.2023.9680 · Cited by 5
“As a result, patients with Alzheimer’s disease reported worsening mood symptoms, such as loneliness, depression, hallucinations, anxiety, agitation, and aberrant motor behavior along with cognitive defects, such as memory loss and compromised recall ability [47, 64, 66–68, 70, 85, 86].”
BackgroundPennella, B., Rotunno, F., Mercuri, M., Guerci, M., Molteni, M., Biancucci, M., Berton, C., Troian, F., Tripodi, P. M., Gilio, A., et al. (2024) · Italian Journal of Medicine · doi:10.4081/itjm.2024.1707 · Cited by 3
AboJabel, H., Idilbi, N. M., & Werner, P. (2021) · Journal of Aging Studies · doi:10.1016/j.jaging.2021.100982 · Cited by 4
COVID-19: Some unresolved issues
Gómez‐Pavón, J., del Castillo, J. M. G., Delgado, M. C. M., Martín‐Sánchez, F. J., Martínez‐Sellés, M., Molero, J., Guillén, S. M., Rodríguez‐Artalejo, F., Ruiz‐Galiana, J., Cantón, R., et al. (2022) · Revista Española de Quimioterapia · doi:10.37201/req/028.2022 · Cited by 3
Crivelli, L., Winkler, A. S., Keller, G., Beretta, S., Calandri, I. L., GROOTE, W. D., Fornari, A., Frontera, J. A., Kivipelto, M., Rocha, A. S. L., et al. (2024) · eNeurologicalSci · doi:10.1016/j.ensci.2024.100539 · Cited by 3
“This finding is consistent with other meta-analyses, such as those by Liu [27] and Hariyanto [28], which report that dementia significantly increases the mortality rate in COVID-19 patients.”
Cristofalo, A., Cascini, S., Cesaroni, G., Trappolini, E., Agabiti, N., & Bargagli, A. M. (2025) · Social Science & Medicine · doi:10.1016/j.socscimed.2025.118233 · Cited by 2
Iwamoto, Y., Jung, H., Tanabe, J., Hirohama, K., & Ishii, S. (2026) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.70339 · Cited by 2
COVID-19 and Mental Health: What do Current Research Show Us
Gürcan, G., Korkmaz, Ş. A., Bıçakcı, Ş., & Gürcan, A. (2022) · Eskisehir Medical Journal Eskisehir City Hospital · doi:10.48176/esmj.2022.57 · Cited by 3
Sugimoto, K., Sato, N., Amamiya, Y., & Hosoya, N. (2022) · Journal of Rural Medicine · doi:10.2185/jrm.2022-006 · Cited by 2
Modeling mortality prediction in older adults with dementia receiving COVID-19 vaccination
Radomyslsky, Z., Kivity, S., Alon, Y., & Saban, M. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-04982-7 · Cited by 2
Chacón, L. M. M., García, L. G., Hernández, T. M. C., Fuentes, N. P., Rizo, C. M., Suárez, I. M., Chacón, O. D. L. M. M., Molina, E. A., & Rocha, L. (2022) · Behavioral Sciences · doi:10.3390/bs12070234 · Cited by 2
“In this line, two systematic reviews and meta-analyses showed that the association between dementia and mortality in COVID-19 patients was affected by age and comorbidities [56,57].”
ResultOlder patients with COVID‐19 and neuropsychiatric conditions: A study of risk factors for mortality
Nguyen‐Michel, V., Houot, M., Delorme, C., Sangaré, A., Gales, A. Z., Frazzini, V., Hanin, A., Aissani, D., Trân, T., Oquendo, B., et al. (2022) · Brain and Behavior · doi:10.1002/brb3.2787 · Cited by 2
“Several studies have reported an association between dementia and mortality in patients with COVID-19 (Hariyanto et al., 2021; N. Liu et al., 2020), while our study and several others did not (De Smet et al., 2020; Genet et al., 2020; Graham et al., 2020; Mendes et al., 2020; Ramos-Rincon et al.,…”
BackgroundResultInfluentialEl impacto de las primeras olas pandémicas de la COVID-19 en las personas mayores con demencia
Flores, M. M., López, M. C., & Gómez‐Pavón, J. (2023) · Atención Primaria · doi:10.1016/j.aprim.2023.102622 · Cited by 8
COVID-19 and Neuroinflammation: A Vital Role for Dance/Movement Therapy in Long-Term Health Outcomes
Amro, S. A. A., Barnstaple, R., Schwartz, S., Kabeer, A., & DeSouza, J. F. X. (2023) · American Journal of Dance Therapy · doi:10.1007/s10465-023-09387-4 · Cited by 4
“A meta-analysis conducted by Liu et al., (2020) examining the impact of COVID-19 on dementia patients noted an increase in both infection and mortality rates.”
MethodThe bidirectional links between coronavirus disease 2019 and Alzheimer’s disease
Nouraeinejad, A. (2024) · International Journal of Neuroscience · doi:10.1080/00207454.2024.2327403 · Cited by 1
“Patients with Alzheimer’s disease are at a higher risk of SARS-CoV-2 infection [11, 12, 15, 16] or vice versa [4, 6].”
Impact of dementia on risks of COVID-19 infection and outcomes among older adults in Sweden
Hoang, M. T., Wastesson, J. W., Szilcz, M., Maura, G., Blotière, P., & Johnell, K. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06576-3 · Cited by 4
Gil, T. E., Quazi, M. A., Verma, T., Sohail, A. H., Ikram, H. A., Nasrullah, A., Gangu, K., Farooq, A., & Sheikh, A. B. (2024) · Geriatrics · doi:10.3390/geriatrics9010007 · Cited by 1
“Their cognitive impairments can also impede their ability to understand, interpret, and adhere to preventive measures and treatment protocols, thereby increasing their risk of infection and adverse health outcomes [6].”
BackgroundAlonso, C. F., Fuentes, M. E., García‐Lamberechts, E. J., Mir, S. A., Jiménez, S., Jacob, J., Piñera, P., Gil‐Rodrigo, A., Llorens, P., Putze, G. B., et al. (2024) · Aging & Mental Health · doi:10.1080/13607863.2024.2337144 · Cited by 2
“Several meta-analyses have shown a 2-to 5-fold increased risk of death in hospitalized COVID-19 patients with dementia versus COVID-19 without dementia (July & Pranata, 2021; Liu et al., 2020).”
Risk factors associated with mortality among vaccinated COVID-19 patients: A retrospective study
Lajmiri, H., Ahmadi, N., Ebrahimi, S., Nikoo, H. R., Farrokhnia, M., Heidari, E., & Mousavi, E. (2024) · Journal of Acute Disease · doi:10.4103/jad.jad_88_24 · Cited by 1
Considering People with Dementia and Their Caregivers in Covid‐19 Lockdowns
Viaña, J. N. M. (2021) · The Hastings Center Report · doi:10.1002/hast.1303 · Cited by 1
Demencia como factor pronóstico de la mortalidad por covid-19
Bombón-Albán, P. E. (2022) · Acta neurológica colombiana · doi:10.22379/24224022404 · Cited by 1
Liu, K. Y., Kulatilake, A., Kalafatis, C., Smith, G., King, J. D., Mestres, J. S., Huzzey, L., Ng, N., Kandangwa, P., Elliott, T., et al. (2022) · BJPsych Open · doi:10.1192/bjo.2022.31
The Impact of COVID on Elderly Adults With Dementia and Other Cognitive Disabilities
Silton, N. R., & McClellan, A. (2022) · Advances in psychology, mental health, and behavioral studies (APMHBS) book series · doi:10.4018/978-1-6684-3484-0.ch006 · Cited by 1
Minaya‐Freire, A., Subirana‐Casacuberta, M., Pou-Pujol, G., & Ramon‐Aribau, A. (2023) · Research in Gerontological Nursing · doi:10.3928/19404921-20230405-02
Evidenced-based biological prevention and intervention strategies of dementia: a narrative review
Abukuri, D. N. (2023) · Current Psychology · doi:10.1007/s12144-023-05017-x · Cited by 1
“The need for sensitize the people, particularly its devastating effects (Ball et al., 2020; Cations et al., 2018; Liu et al., 2020; Livingston et al., 2020).”
Sousa, A., Lima, O., Pérez‐González, A., Araujo, A., Longueira, R., Otero, A., Fernández, M. N., Ramos, C., Martínez-Lamas, L., Casal, M. C., et al. (2023) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000001296
Harriman, N. W., Bassil, D. T., Farrell, M. T., du Toit, J., Casas, F. X. G., Tollman, S. M., & Berkman, L. F. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1304572 · Cited by 1
Aydemir, D., Yücel, M., Köseoğlu, M., & Ulusu, N. N. (2024) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2022-0206
Peláez, A., del Árbol, N. R., Sellán, A. V., Castellano, J. M., Soriano, J. B., Ancochea, J., & Peñalvo, J. L. (2024) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2023.12.023
Ma, Q., Ren, J., Chen, L., Guo, W., Feng, K., Huang, T., & Cai, Y. (2024) · Current Bioinformatics · doi:10.2174/0115748936306893240720192301
Metadata
- Authors
- Liu, N., Sun, J., Wang, X., Zhao, M., Huang, Q., & Li, H.
- Affiliations
- Xiyuan Hospital (CN)
- Beijing University of Chinese Medicine (CN)
- Corresponding author
- Li, Hao
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2020-12-08
- Volume
- 78
- Issue
- 4
- Pages
- 1775-1782
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W3110517956
- Cited by
- 110
- References
- 37
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 24 · 2023: 26 · 2022: 32 · 2021: 17
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- Journal of Alzheimer s Disease (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Funders
- National Science and Technology Major Project
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- COVID-19 pandemic, dementia
- MeSH terms
- COVID-19, Aged, Aged, 80 and over, Alzheimer Disease, Dementia, Female, Humans, Male, Middle Aged, Incidence, Prevalence, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.